NasdaqGS:ONCBiotechs
BeOne Medicines Pharma Alliances Contrast With High P/E And Valuation Upside
BeOne Medicines, listed as NasdaqGS:ONC, announced new collaborations with Amgen, Bristol Myers Squibb, and Novartis.
The partnerships are focused on advancing BeOne Medicines' oncology therapy pipeline alongside its existing commercial products.
The company also highlighted ongoing clinical trials that sit alongside these new pharma alliances.
BeOne Medicines operates in oncology, an area where large pharma groups and smaller specialists often work together to bring new treatments through...